We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Get PharmaCyte Biotech alerts: PharmaCyte Biotech (NASDAQ:PMCB – Get Free Report) last posted its quarterly earnings data on Monday, March 17th. The company reported ($0.10) earnings per share ...

Short interest in PharmaCyte Biotech Inc (NASDAQ:PMCB) decreased during the last reporting period, falling from 26.76K to 20.23K. This put 0.33% of the company's publicly available shares short.

LAS VEGAS, May 21, 2024--PharmaCyte Biotech, Inc. (Nasdaq: PMCB) ("PharmaCyte" or the "Company"), today announced a $7 million investment in MyMD Pharmaceuticals, Inc ...